Medco Health Reaches New 52-Week High (MHS)

NEW YORK ( TheStreet) -- Medco Health Solutions (NYSE: MHS) hit a new 52-week high Monday as it is currently trading at $67, above its previous 52-week high of $66.38 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Medco Health has a market cap of $24 billion and is part of the services sector and wholesale industry. Shares are up 14.7% year to date as of the close of trading on Friday.

Medco Health Solutions, Inc., a healthcare company, provides clinically-driven pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals primarily in the United States. The company has a P/E ratio of 17.7, below the average wholesale industry P/E ratio of 18.1 and equal to the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medco Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Medco Health Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing